S100A8/A9 has been shown to be an endogenous ligand of Toll-like receptor-4 (TLR-4), to be associated with human sepsis and endotoxemia, and to play an important role in innate immunity [10,11,12]. Here, TLR4 is linked to serum lipopolysaccharide activity.